ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 学会発表・講演等
  2. 口頭発表

Radiotherapy responsive markers in sequential biopsy samples from cervical cancer patients during fractionated radiotherapy.

https://repo.qst.go.jp/records/62734
https://repo.qst.go.jp/records/62734
1a2472bd-880f-4f5e-abbe-782e83c90d97
Item type 会議発表用資料 / Presentation(1)
公開日 2008-09-22
タイトル
タイトル Radiotherapy responsive markers in sequential biopsy samples from cervical cancer patients during fractionated radiotherapy.
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_c94f
資源タイプ conference object
アクセス権
アクセス権 metadata only access
アクセス権URI http://purl.org/coar/access_right/c_14cb
著者 Iwakawa, Mayumi

× Iwakawa, Mayumi

WEKO 619628

Iwakawa, Mayumi

Search repository
Ohno, Tatsuya

× Ohno, Tatsuya

WEKO 619629

Ohno, Tatsuya

Search repository
Tamaki, Tomoaki

× Tamaki, Tomoaki

WEKO 619630

Tamaki, Tomoaki

Search repository
Kato, Shingo

× Kato, Shingo

WEKO 619631

Kato, Shingo

Search repository
Nakawatari, Miyako

× Nakawatari, Miyako

WEKO 619632

Nakawatari, Miyako

Search repository
Imai, Takashi

× Imai, Takashi

WEKO 619633

Imai, Takashi

Search repository
岩川 眞由美

× 岩川 眞由美

WEKO 619634

en 岩川 眞由美

Search repository
大野 達也

× 大野 達也

WEKO 619635

en 大野 達也

Search repository
田巻 倫明

× 田巻 倫明

WEKO 619636

en 田巻 倫明

Search repository
加藤 眞吾

× 加藤 眞吾

WEKO 619637

en 加藤 眞吾

Search repository
中渡 美也子

× 中渡 美也子

WEKO 619638

en 中渡 美也子

Search repository
今井 高志

× 今井 高志

WEKO 619639

en 今井 高志

Search repository
抄録
内容記述タイプ Abstract
内容記述 We previously reported radiotherapy-responsive genes, which were revealed by comprehensive transcriptome analysis using the microarray technology for sequential biopsies for cervical cancer patients with radiotherapy (RT). We found several tens of RT-responsive genes, including well-known radiation-responsive apoptosis/cell cycle-related genes, such as cdkn1a/p21, CAD, and Bax, and several tens of genes categorized into extracellular matrix (ECM), such as HPSE and CD44. In addition, several cytokines were also included.
In this study, we investigated the possibility that some of those molecules, which were changed their expressions by RT, might be new biomarkers for the effectiveness of RT. Sequential biopsy samples were immunohistochemically analyzed before and during RT in cervical cancer patients, and the prognostic value of such changes of 15 candidate molecules for disease failure after RT were evaluated.
\nPatients and Methods: Biopsy specimens were obtained from 91 patients with cervical cancers before (pretreatment) and 1 week after initiation (midtreatment) of radiotherapy. which were in RT-responsive genes or related with those genes, were performed to detect protein expression using an automated streptavidin-biotin immunoperoxidase staining system. Positive area/numbers of cells proportion (%) of immunostaining were analyzed using an image analysis system or the positive staining appearance was scored by grading system. Patients were defined as good or poor responders based on their two-year disease-free survival. Aberrant genomic change, human papillomavirus infection, and p53 status in tumor were also evaluated.
\nResults: Protein expression of cdkn1a/p21, Bax, p53 and FGF2 in midtreatment samples (mid) was significantly higher than in pretreatment samples (pre). Protein expression of P-cadherin, ICAD, S100, p73 and VEGF in mid was significantly lower than in pre. Discontinuity of laminin staining pattern in mid was significantly higher than in pre. The ratio change (mid versus pre) of FGF2 expression in poor responders was significantly lower than that in good responders (P < 0.05). The number of cases with discontinuity of laminin staining pattern at pre was significantly higher in the poor responders (P < 0.05).
\nConclusions: Using biopsy specimens from pretreatment and midtreatment cervical cancers, we revealed significant changes in expression of several proteins during fractionated radiotherapy. We also found that some of these ratio changes were significantly associated with prognosis. These molecular features in sequential biopsy samples might help us to identify patients at high risk of disease failure after radiotherapy and to provide tool for personalized radiotherapy.
会議概要(会議名, 開催地, 会期, 主催者等)
内容記述タイプ Other
内容記述 European Society for Therapeutic Radiology and Oncology Annual Congress(ESTRO27)
発表年月日
日付 2008-09-18
日付タイプ Issued
戻る
0
views
See details
Views

Versions

Ver.1 2023-05-15 21:27:23.940519
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3